You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

biopharmaceutical

Showing 1 - 25 of 252
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Chongqing (PEG-rhG-CSF, RhG-CSF)

Recruiting
  • Lymphoma
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
Aug 31, 2023

Soluble B7-H3 as a Biomarker for Osteosarcoma

Recruiting
  • Biomarker
  • +3 more
  • ELISA: enzyme-linked immunosorbent assay
  • Beijing, Beijing, China
    Peking University People's Hospital
Jul 5, 2023

Diabetic Macular Edema Trial in Beijing (ASKG712)

Not yet recruiting
  • Diabetic Macular Edema
  • ASKG712
  • Beijing, China
    Peking Union Medical College Hospital, Chinese Academy of Medica
Jul 12, 2023

Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)

Recruiting
  • Hemophilia A
  • Single dose intravenous injection of BBM-H803
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital Chinese Academ
Oct 31, 2023

Peritoneal Metastases, Colorectal Cancer Trial in Hangzhou (Hyperthermic intraperitoneal treatment of recombinant modified human

Recruiting
  • Peritoneal Metastases
  • Colorectal Cancer
  • Hyperthermic intraperitoneal treatment of recombinant modified human tumor necrosis factor (rmhTNF)
  • Hangzhou, Zhejiang, China
    2nd Affiliated Hospital, School of Medicine, Zhejiang University
Mar 2, 2023

Type 2 Diabetes Trial (ZT002, Placebo)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • (no location specified)
Aug 4, 2022

NSCLC Trial (SKB264, Pemetrexed, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
May 23, 2023

NSCLC Trial in Guangzhou (SKB264, Pembrolizumab, Carboplatin)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Apr 14, 2023

Malignant Solid Tumor Trial in Hackensack, New York, Spokane (ZL-1218, Pembrolizumab)

Recruiting
  • Malignant Solid Tumor
  • Hackensack, New Jersey
  • +2 more
May 4, 2023

Healthy Trial in Beijing (AK3280, Placebo)

Completed
  • Healthy
  • Beijing, China
    China-Japan Friendship Hospital
Apr 6, 2022

Malignant Pleural Effusion, Malignant Peritoneal Effusion Trial in Wuhan (Virus Activated Killer immune Cells, Saline)

Recruiting
  • Malignant Pleural Effusion
  • Malignant Peritoneal Effusion
  • Virus Activated Killer immune Cells
  • Saline
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 29, 2022

Ovarian Cancer Trial in Wuhan (KM1, Chemotherapy)

Not yet recruiting
  • Ovarian Cancer
  • Wuhan, Hubei, China
    Tongji Hospital of Tongji Medical College, Huazhong University o
Jan 5, 2023

Neovascular Age-related Macular Degeneration Trial (ASKG712)

Not yet recruiting
  • Neovascular Age-related Macular Degeneration
  • ASKG712
  • (no location specified)
Jul 10, 2022

Advanced Gastric Carcinoma, HER2-positive Gastric Cancer Trial in ZhengZhou (RC48+AK105+cisplatin)

Not yet recruiting
  • Advanced Gastric Carcinoma
  • HER2-positive Gastric Cancer
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Mar 29, 2022

Uterine Cervical Tumors Trial in Wuhan (BS-006)

Not yet recruiting
  • Uterine Cervical Neoplasms
  • BS-006
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jun 6, 2022

Idiopathic Pulmonary Fibrosis Trial in Beijing (AK3280, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Jul 19, 2022

Hypertrophic Scar Trial in Shanghai (AK3280 Cream, Placebo cream)

Not yet recruiting
  • Hypertrophic Scar
  • AK3280 Cream
  • Placebo cream
  • Shanghai, Shanghai, China
    Shanghai Ninth People's Hospital,Shanghal JiaoTong University Sc
Jul 4, 2022

Advanced Solid Tumor Trial in Chengdu (KL590586 Capsule)

Enrolling by invitation
  • Advanced Solid Tumor
  • KL590586 Capsule
  • Chengdu, Sichuan, China
    Sichuan Kelun Botai Biopharmaceutical Co.
Feb 23, 2022

Healthy Trial in Manchester (Glycopyrrolate)

Completed
  • Healthy
  • Manchester, United Kingdom
    Medicines Evaluation Unit
Oct 28, 2021

NSCLC Trial (Sintilimab, Anlotinib)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • (no location specified)
Mar 23, 2022

Advanced Solid Tumors (Including GCTTS) Trial in Shanghai (BC006)

Recruiting
  • Advanced Solid Tumors (Including GCTTS)
  • Shanghai, Shanghai, China
    Dragonboat Biopharmaceutical,Co.,Ltd
Jan 16, 2022

Parkinson's Disease Trial in Irvine, San Francisco, Columbus (AAV2-GDNF)

Recruiting
  • Parkinson's Disease
  • AAV2-GDNF
  • Irvine, California
  • +2 more
Feb 8, 2022

Leukemia, Myeloid, Acute Trial in Chongqing (anti-CD33 CAR NK cells, Fludarabine, Cytoxan)

Recruiting
  • Leukemia, Myeloid, Acute
  • anti-CD33 CAR NK cells
  • +2 more
  • Chongqing, Chongqing, China
    Department of Hematology, Xinqiao Hospital
Dec 22, 2021

Muscle Weakness Trial in Lexington (HMB, hydroxymethylbutyrate, EPA, eicosapentaenoic acid, Saline)

Completed
Has Results
  • Muscle Weakness
  • HMB, hydroxymethylbutyrate
  • +2 more
  • Lexington, Kentucky
    Chandler Hospital
Apr 5, 2021

Solid Tumor, Adult Trial in Shanghai (HOT-1030)

Recruiting
  • Solid Tumor, Adult
  • Shanghai, Shanghai, China
    Shanghai Huaota Biopharmaceutical Co., Ltd.
Sep 17, 2021